Abstract
Resveratrol is a naturally occurring polyphenol found abundantly in red grapes and red wine. It has been found to be antioxidant, anti-inflammatory, anti-carcinogenic, and antibacterial from the extensive research during the last two decades. It modulates various multiple biological pathways and hence exerts its chemopreventive and chemotherapeutic effects (Chung et al. 2013).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aziz MH, Afaq F, Ahmad N et al (2005) Prevention of ultraviolet-B radiation damage by resveratrol in mouse skin is mediated via modulation in survivin. Photochem Photobiol 81:25–31
Banerjee S, Bueso-Ramos C, Aggarwal BB (2002) Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62:4945–4954
Bhat KPL, Lantvit D, Christov K et al (2001) Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res 61:7456–7463
Bishayee A, Barnes KF, Bhatia D et al (2010) Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis. Cancer Prev Res 3:753–763
Brown VA, Patel KR, Viskaduraki M et al (2010) Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 70:9003–9011
Carb’o N, Costelli P, Baccino FM et al (1999) Resveratrol, a natural product present in wine,decreases tumour growth in a rat tumour model. Biochem Biophys Res Commun 254:739–743
Chung MY, Lim TG, Lee KW (2013) Molecular mechanisms of chemopreventive phytochemicals against gastroenterological cancer development. World J Gastroenterol 19:984–993
Garvin S, Ollinger K, Dabrosin C (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231(113–122):2006
Harper CE, Patel BB, Wang J et al (2007) Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis 28:946–1953
Kalra N, Roy P, Prasad S et al (2008) Resveratrol induces apoptosis involving mitochondrial pathways in mouse skin tumorigenesis. Life Sci 82:348–358
Kimura Y, Okuda H (2001) Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in lewis lung carcinoma-bearing mice. J Nutr 131:1844–1849
Lee EO, Lee HJ, Hwang HS et al (2006) Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities. Carcinogenesis 27:2059–2069
Lin HC, Chen YF, Hsu WH et al (2012) Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res (Phila) 5:952–962
Liu P, Liang H, Xia Q et al (2013) Resveratrol induces apoptosis of pancreatic cancers cells by inhibiting miR-21 regulation of BCL- 2 expression. Clin Transl Oncol 15:741–746
Luo H, Wang L, Schulte BA et al (2013) Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells. Int J Oncol 43:1999–2006
Malhotra A, Bath S, Elbarbry F (2015) An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol. Oxid Med Cell Longev 2015:803971
Nguyen AV, Martinez M, Stamos MJ et al (2009) Results of a phase I pilot clinical trial examining the effect of plant derived resveratrol and grape powder on wnt pathway target gene expression in colonic mucosa and colon cancer. Cancer Manag Res 1:25–37
Oi N, Jeong CH, Nadas J et al (2010) Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A(4) hydrolase. Cancer Res 70:9755–9764
Popat R, Plesner T, Davies F et al (2013) A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma. Br J Haematol 160:714–717
Provinciali M, Re F, Donnini A et al (2005) Effect of resveratrol on the development of spontaneous mammary tumors in HER- 2/neu transgenic mice. Int J Cancer 115:36–45
Roy SK, Chen Q, Fu J et al (2011) Resveratrol inhibits growth of orthotopic pancreatic tumors through activation of FOXO transcription factors. PLoS One 6:e25166
Schneider Y, Duranton B, Goss’e F et al (2001) Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39:102–107
Seeni A, Takahashi S, Takeshita K et al (2008) Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model. Asian Pac J Cancer Prev 9:7–14
Soleas GJ, Grass L, Josephy PD et al (2002) A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 35:119–124
Tessitore L, Davit A, Sarotto I et al (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21:1619–1622
Wu SL, Sun ZJ, Yu L et al (2004) Effect of resveratrol and in combination with 5-FU on murine liver cancer. World J Gastroenterol 10:3048–3052
Zhou HB, Chen JJ, Wang WX et al (2005) Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol 11:280–284
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Rashid, S. (2017). Chemoprevention by Resveratrol. In: Cancer and Chemoprevention: An Overview. Springer, Singapore. https://doi.org/10.1007/978-981-10-2579-2_16
Download citation
DOI: https://doi.org/10.1007/978-981-10-2579-2_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-2578-5
Online ISBN: 978-981-10-2579-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)